These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30402850)

  • 1. Increased HSPG2 expression independently predicts poor survival in patients with oligoastrocytoma and oligodendroglioma.
    Ma XL; Shang F; Ni W; Zhu J; Luo B; Zhang YQ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6853-6863. PubMed ID: 30402850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia.
    Zhou X; Liang S; Zhan Q; Yang L; Chi J; Wang L
    Cell Death Dis; 2020 Jun; 11(6):492. PubMed ID: 32606327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.
    Kazanskaya GM; Tsidulko AY; Volkov AM; Kiselev RS; Suhovskih AV; Kobozev VV; Gaytan AS; Aidagulova SV; Krivoshapkin AL; Grigorieva EV
    Histochem Cell Biol; 2018 Mar; 149(3):235-244. PubMed ID: 29322326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
    Gong Y; Yang J; Wu W; Liu F; Su A; Li Z; Zhu J; Wei T
    PLoS One; 2018; 13(5):e0197007. PubMed ID: 29723302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of heparan sulfate proteoglycan (perlecan, HSPG2), lipid profiles and coronary artery disease in the Australian population.
    Cai H; Wang XL; Wilcken DE
    Atherosclerosis; 2000 Jan; 148(1):125-9. PubMed ID: 10580178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant NEK2 expression might be an independent predictor for poor recurrence-free survival and overall survival of skin cutaneous melanoma.
    Huang J; Sun SG; Hou S
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3694-3702. PubMed ID: 29949142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
    Zhong M; Jiang Q; Jin R
    IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
    Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
    Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study.
    Ding X; Wang Z; Chen D; Wang Y; Zhao Z; Sun C; Chen D; Tang C; Xiong J; Chen L; Yao Z; Liu Y; Wang X; Cahill DP; de Groot JF; Jiang T; Yao Y; Zhou L
    J Neurooncol; 2018 Dec; 140(3):591-603. PubMed ID: 30206763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perlecan-deficient mutation impairs corneal epithelial structure.
    Inomata T; Ebihara N; Funaki T; Matsuda A; Watanabe Y; Ning L; Xu Z; Murakami A; Arikawa-Hirasawa E
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1277-84. PubMed ID: 22266517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated therapeutic strategy for adult low-grade glioma stratified by resection and tumor subtype.
    Nitta M; Muragaki Y; Maruyama T; Iseki H; Ikuta S; Konishi Y; Saito T; Tamura M; Chernov M; Watanabe A; Okamoto S; Maebayashi K; Mitsuhashi N; Okada Y
    Neurol Med Chir (Tokyo); 2013; 53(7):447-54. PubMed ID: 23883555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization, expression profiles of the porcine SDC2 and HSPG2 genes and their association with hematologic parameters.
    Wang W; Tao C; Zhou P; Zhou X; Zhang Q; Liu B
    Mol Biol Rep; 2013 Mar; 40(3):2549-56. PubMed ID: 23264070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X; Chen L; Zhang T
    Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment.
    Warren CR; Grindel BJ; Francis L; Carson DD; Farach-Carson MC
    J Cell Biochem; 2014 Jul; 115(7):1322-33. PubMed ID: 24700612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can rs3767140 SNP of the perlecan (HSPG2) gene affect the diabetes mellitus through the dyslipidemia?
    Kurnaz-Gömleksiz Ö; Tokat B; Aslan EI; Yanar F; Ermiş-Karaali Z; Öztürk O; Yilmaz-Aydoğan H
    Cell Mol Biol (Noisy-le-grand); 2016 Jul; 62(8):35-9. PubMed ID: 27545212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STK24 expression is modulated by DNA copy number/methylation in lung adenocarcinoma and predicts poor survival.
    Huang N; Lin W; Shi X; Tao T
    Future Oncol; 2018 Sep; 14(22):2253-2263. PubMed ID: 29557182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
    McNamara MG; Jiang H; Lim-Fat MJ; Sahebjam S; Kiehl TR; Karamchandani J; Coire C; Chung C; Millar BA; Laperriere N; Mason WP
    Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome.
    Stum M; Davoine CS; Vicart S; Guillot-Noël L; Topaloglu H; Carod-Artal FJ; Kayserili H; Hentati F; Merlini L; Urtizberea JA; Hammouda el-H; Quan PC; Fontaine B; Nicole S
    Hum Mutat; 2006 Nov; 27(11):1082-91. PubMed ID: 16927315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma.
    Tanaka K; Sasayama T; Mizukawa K; Takata K; Sulaiman NS; Nishihara M; Kohta M; Sasaki R; Hirose T; Itoh T; Kohmura E
    Clin Neurol Neurosurg; 2015 Nov; 138():37-44. PubMed ID: 26276726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.